Latest Tonic–clonic seizure Stories
Eisai Submits Applications for Antiepilepsy Agent Fycompa Simultaneously In Europe and U.S.
LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Recently FDA Approved Qudexy(TM) XR Offers a New Treatment Option for Managing Specific Seizure Types MAPLE GROVE, Minn., June 17, 2014 /PRNewswire/ -- Results from
Upsher-Smith-sponsored data to include the first presentation of pooled Phase 1 data on the adverse event profile of USL255 (Qudexy(TM) XR (topiramate) extended-release capsules) MAPLE GROVE,
Patrick Shannon won’t allow a medical condition to keep him from long-distance hiking.
A Loyola University Medical Center neurologist is reporting surprising results of a study of patients who experience both epileptic and non-epileptic seizures.
A 25-year follow-up study reveals that 68% of patients with juvenile myoclonic epilepsy (JME) became seizure-free, with nearly 30% no longer needing antiepileptic drug (AED) treatment.
The 5K Walk/Run Highlights Efforts to Heighten Awareness for an Often Overlooked and Under Supported Disorder that Affects about 200,000 Individuals Across Southern California Pasadena,
A recent multi-center study determined that women with generalized tonic-clonic seizures (GTCS) had a greater number of seizures during anovulatory cyclesâ€”menstrual cycles where an egg is not releasedâ€”than in cycles where ovulation occurs.
- Emitting flashes of light; glittering.